Navigation Links
Surveyed Physicians Report that Invokana Captures a Small Percentage of Patient Share in the Type 2 Diabetes Drug Market, With Significant Increases Expected Six Months from Now
Date:10/31/2013

EXTON, Pa., Oct. 31, 2013 /PRNewswire/ -- BioTrends Research Group, one of the world's leading research and advisory firms for specialized biopharmaceutical issues, finds that, among surveyed endocrinologists and primary care physicians (PCPs), Janssen Pharmaceuticals' Invokana captures a small percentage of type 2 diabetes patient share, with significant increases expected six months from now. Currently, a majority of type 2 diabetes patients are using metformin (excluding fixed-dose combinations) and one-third of patients are treated with long-acting insulins such as Sanofi's Lantus or Novo Nordisk's Levemir.

(Logo: http://photos.prnewswire.com/prnh/20130103/MM36805LOGO

The TreatmentTrends®: Type 2 Diabetes (U.S.) 2013 report also finds that, within the GLP-1 drug class, Novo Nordisk's Victoza is the patient share leader, followed by Bristol-Myers Squibb/AstraZeneca's Byetta/Bydureon (if these products are considered independently).

The report examines five products in development for the treatment of type 2 diabetes—Bristol-Myers Squibb/AstraZeneca's dapagliflozin, GlaxoSmithKline's albiglutide, Eli Lilly's dulaglutide, Novo Nordisk's Tresiba and Takeda's fasiglifam. After reviewing a product profile, surveyed endocrinologists indicated a higher mean interest level for the long-acting insulin Tresiba versus the SGLT-2 inhibitor dapagliflozin.

"The report focuses on physician perception of type 2 diabetes product satisfaction, attribute importance, product performance and sales representative frequency and performance," said BioTrends Research Group Director Rob Dubman. "For example, the study found that at least 40 percent of surveyed physicians have seen a sales representative in the past m
'/>"/>

SOURCE BioTrends Research Group
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Surveyed U.S. Rheumatologists are Moderately Satisfied with Biologic Agents and Xeljanz to Treat Rheumatoid Arthritis
2. More than a Third of Chronic Kidney Disease-Non-Dialysis Patients are Likely Candidates for FG-4592/ASP1517, According to Surveyed EU5 Nephrologists
3. At One Month Post-Launch, Nearly a Quarter of Surveyed U.S. Oncologists Have Prescribed Tafinlar for Malignant Melanoma, Compared to 15 Percent Who Used Mekinist
4. Should Mircera Reach the U.S. Market, Surveyed Nephrologists State that at Least 40 Percent of CKD-ND and Dialysis Patients are Likely Candidates
5. According to Surveyed U.S. Oncologists, Zytiga is the Patient-Share Leader in First-Line Metastatic Castrate-Resistant Prostate Cancer
6. Surveyed U.S. Neurologists Report Greater Overall Satisfaction with Tecfidera than with Platform Injectables and Other Oral Multiple Sclerosis Therapies
7. At One Month Post-Launch, Nearly One-Quarter of Surveyed U.S. Medical Oncologists Have Prescribed Xofigo to Their Prostate Cancer Patients
8. A Significant Share of Surveyed Treatment-Naive and Prior Failure HCV Patients Plan to Initiate an HCV Treatment Regimen in the Next Year
9. Surveyed U.S. Neurologists Are More Likely Than Payers to Consider Biogen Idecs Tecfidera to be a Breakthrough in the Treatment of Multiple Sclerosis
10. Up to Sixty Percent of Surveyed U.S. Managed Care Organization Directors Expect to Cover Key Emerging Therapies for Parkinsons Disease on Their Largest Commercial Plan
11. The Majority of Surveyed Oncologists Prescribe Avastin Off-label to Their Ovarian Cancer Patients; However Approximately Half Encounter Access and Reimbursement Hurdles
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... 2014   Mast Therapeutics, Inc. (NYSE ... that Santosh Vetticaden, Chief Medical Officer and Senior ... personal reasons, in mid-September.  Edwin L. Parsley ... Pharmaceuticals, which Mast acquired earlier this year, will ... interim Chief Medical Officer.  Dr. Parsley previously was ...
(Date:8/29/2014)... , Aug. 29, 2014 Research and ... "China Orthopedic Instrument Industry Report, 2014-2017" report to ... population and rising proportion of reimbursement for medical expenses, ... released, with its scale presenting a CAGR of 19.2% ... are three product segments of orthopedic instruments in ...
(Date:8/29/2014)... Does your doctor know what you,re smoking?  Chances ... marijuana to the over 112,000 currently registered patients under ... the other roughly 20,300+ active physicians listed with the Colorado ... – even though a poll in February 2014 showed 51% ... tried it. "With marijuana legalization underway, every ...
Breaking Medicine Technology:Mast Therapeutics Announces Management Change 2Mast Therapeutics Announces Management Change 3Mast Therapeutics Announces Management Change 4China Orthopedic Instrument Industry Report, 2014-2017 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 2Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 3Medical Rules Marijuana Sales in Colorado But Most Doctors Still in the Dark 4
... Colo. , May 10 Heska Corporation (Nasdaq: HSKA ) today ... Wednesday, May 12, 2010 .  The presentation will be at The Intercontinental Hotel ... and is scheduled to begin at 9:55 a.m. Eastern Time . , ... (Logo:   http://www.newscom.com/cgi-bin/prnh/20000622/HESKALOGO ) , ...
... May 10 Dr. Richard Hays ... diagnosed type 1 diabetes for Protege Encore, a randomized, placebo-controlled ... Phase III studies testing the safety and efficacy of an ... has completed enrollment of more than 530 subjects with type ...
Cached Medicine Technology:Protege Encore Clinical Trial Evaluates New Investigational Approach For Individuals Recently Diagnosed With Type 1 Diabetes 2
(Date:8/29/2014)... August 30, 2014 Skmen.com, a famous online ... sexy mini dresses . At the moment, all these ... percent off. The deadline of the promotion is September 14. ... clients with the latest information about our hot designs, we ... store. We hope to help all stylish ladies to get ...
(Date:8/29/2014)... Inc., a leading provider of scalable Asterisk-based contact center ... its Q-Suite 5.7 software. As a global provider ... deploying and supporting its ACD and Dialer software suite ... for more than a decade. The introduction of usage-based ... complements the widespread deployment of Q-Suite in the Cloud. ...
(Date:8/29/2014)... Developed as a nod to post-war ... Canada Goose products offer the mobility, durability and ... runways. The company’s Canada Goose Chilliwack bombers ... market. Additionally, the firm has unveiled its new bomber ... At present, all high quality Chilliwack bombers are provided ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 As reported by ... Monitoring For Drug Abuse Trends , Outbreaks (8/20), the National ... attempt to monitor drug abuse trends by turning to social ... drug abuse trends, it is also working with the University ... National Drug Early Warning System, which will be funded by ...
(Date:8/29/2014)... Formed in 2014, KAJ Brothers is a unique group ... Their sophisticated Pop/R&B sound, with beautiful orchestral elements is not ... experience every day. , The band has a ... with the primary purpose of elevating women with true love ... replied - “To make chivalry cool again, and help raise ...
Breaking Medicine News(10 mins):Health News:Cheap Sexy Mini Dresses Added To The Product Line Of Skmen.com 2Health News:Indosoft Offers Monthly Usage Licensing Terms 2Health News:New Designs Of Canada Goose Chilliwack Bombers From DoudouneCanadienneGoosePasCher.fr 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 2Health News:Social Media Proves to Be Helpful in Fighting Drug Abuse 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 2Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 3Health News:KAJ Brothers Commits $10,000 to International Justice Mission To End Human Sex Trafficking and Challenges Other Artists and Celebrities To Do Likewise 4
... Steven Reinberg HealthDay Reporter , TUESDAY, May 31 ... reduction in premiums and an easing of standards for the ... to get health insurance. Premiums under the Pre-Existing ... Act, will drop as much as 40 percent in 18 ...
... By Maureen Salamon HealthDay Reporter , ... studies linking genes, proteins and other so-called "biomarkers" with ... suggests. Analyzing 35 of the most frequently cited ... biomedical journals, study authors found that fewer than half ...
... A facelift incision and robotics can help surgeons safely ... patients without the characteristic neck scar. Georgia Health ... access capabilities of robots, experience gained from another no-neck-scar ... largest salivary gland from the lower jaw region. "It ...
... , TUESDAY, May 31 (HealthDay News) -- Violent ... according to a new University of Missouri study. ... become less responsive, or desensitized, to violence -- a ... "From a psychological perspective, video games are excellent teaching ...
... the 30 years since the first reported cases of ... made extraordinary advances in understanding, treating and preventing the ... National Institute of Allergy and Infectious Diseases (NIAID), part ... on those successes to control and, ultimately, end the ...
... , TUESDAY, May 31 (HealthDay News) -- As ... time with cyber time -- a trend leading one ... such as "sexting" and cyberbullying. "The Internet is a ... games and educational lessons, David Schwebel, a psychology professor at ...
Cached Medicine News:Health News:U.S. Makes It Easier to Get Insurance With Pre-Existing Conditions 2Health News:Tie Between 'Biomarkers,' Disease Often Overstated, Scientists Say 2Health News:Tie Between 'Biomarkers,' Disease Often Overstated, Scientists Say 3Health News:Facelift incision offers safe option for some thyroid patients 2Health News:Facelift incision offers safe option for some thyroid patients 3Health News:Violent Video Games Linked to Increased Aggression 2Health News:Parents Should Screen Kids' Summer Web Surfing: Expert 2
... Plate is a semi-rigid system intended ... The Slim-LOC is based on the ... current market technology. The Slim-LOC system ... instrumentation. Reduced width (16 mm), low ...
... is an Anterior Cervical Plating System ... flexibility and simplicity for the spinal ... function and safe fixation of the ... meet the needs of the spinal ...
... is intended for supportive stabilization of ... fusion. The device utilizes bi-cortical fixation ... is enhanced through dynamic screw holes ... single level interbody fusion. Anterior cervical ...
... designed to meet the clinical challenges of ... locking mechanism and the choice of fixed ... angle screws for ease of implantation in ... system allows the surgeon the versatility of ...
Medicine Products: